EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Inflammatory Biomarkers and Outcome Heterogeneity in Anti-MDA5 Antibody-Associated Interstitial Lung Disease: A Single-Center Consecutive Cohort Study

Akina Nigi iD, Keisuke Iwamoto, Hidetoshi Itani, Shigeto Kondou, Yuki Okunishi iD, Takahiro Ohnishi

Advances in Respiratory Medicine · 28.04.2026 · 94 (3) · 29

DOI: 10.3390/arm94030029 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Advances in Respiratory Medicine, online erschienen am 28.04.2026. Verfasst von Akina Nigi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Japanese Red Cross Ise Hospital, 471-2 Funae, Ise 516-8512, Mie, Japan. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Interferon-Induced Helicase, IFIH1, Autoantibodies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody-positive interstitial lung disease (ILD) is associated with high mortality. While inflammatory markers have been linked to poor outcomes, clinical heterogeneity remains evident, as some patients survive despite marked hyperinflammation.

Methods

We retrospectively analyzed consecutive patients with anti-MDA5 antibody-positive ILD treated at our institution between May 2017 and November 2025. In-hospital mortality was assessed in relation to clinical characteristics and laboratory markers, including peak anti-MDA5 antibody titers, ferritin, C-reactive protein (CRP), lactate dehydrogenase (LDH), and KL-6. Analyses were exploratory and hypothesis-generating. Continuous variables were compared using Mann–Whitney U tests, and categorical variables using Fisher’s exact test. Principal component analysis (PCA) and receiver operating characteristic (ROC) analyses were performed for descriptive purposes.

Results

Seventeen patients were included (10 survivors and 7 non-survivors). Peak ferritin, C-reactive protein (CRP), and lactate dehydrogenase (LDH) levels were significantly higher in non-survivors, whereas peak anti-MDA5 antibody titers showed a non-significant trend toward higher values in non-survivors (p = 0.057). KL-6 levels did not differ significantly between groups. In ROC analyses, LDH and CRP showed the highest discriminative performance for in-hospital mortality, followed by ferritin, whereas KL-6 showed the lowest discriminative performance. Despite these overall trends, substantial overlap between survivors and non-survivors remained across all biomarkers. Principal component analysis (PCA) demonstrated partial separation of outcomes along an inflammation-dominant axis, but with persistent overlap, indicating marked outcome heterogeneity.

Conclusions

Inflammatory biomarkers, particularly LDH, CRP, and ferritin, were associated with in-hospital mortality in anti-MDA5 antibody-associated ILD. However, persistent overlap between survivors and non-survivors suggests that single-biomarker assessment is insufficient for precise prognostication. These findings should be interpreted as hypothesis-generating and require validation in larger multicenter cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialInterferon-Induced Helicase, IFIH1AutoantibodiesHumansBiomarkersFemaleMaleRetrospective StudiesC-Reactive ProteinL-Lactate DehydrogenaseFerritinsAgedMiddle AgedHospital MortalityCohort Studies

Stichwörter der Autor:innen

C-reactive proteinanti-MDA5 antibodybiomarkersdermatomyositisferritininterstitial lung diseaselactate dehydrogenasemortality

Substanzen

BiomarkersC-Reactive ProteinInterferon-Induced Helicase, IFIH1L-Lactate DehydrogenaseFerritinsIFIH1 protein, humanAutoantibodies

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Japanese Red Cross Ise Hospital, 471-2 Funae, Ise 516-8512, Mie, Japan.
  • Department of Rheumatology Medicine, Japanese Red Cross Ise Hospital, 471-2 Funae, Ise 516-8512, Mie, Japan.

ORCID-Profile: Akina Nigi, Yuki Okunishi

Zitieren

APA

Nigi, A., Iwamoto, K., Itani, H., Kondou, S., Okunishi, Y., & Ohnishi, T. (2026). Inflammatory Biomarkers and Outcome Heterogeneity in Anti-MDA5 Antibody-Associated Interstitial Lung Disease: A Single-Center Consecutive Cohort Study. Advances in Respiratory Medicine, 94(3), 29. https://doi.org/10.3390/arm94030029

Vancouver

Nigi A, Iwamoto K, Itani H, Kondou S, Okunishi Y, Ohnishi T. Inflammatory Biomarkers and Outcome Heterogeneity in Anti-MDA5 Antibody-Associated Interstitial Lung Disease: A Single-Center Consecutive Cohort Study. Advances in Respiratory Medicine. 2026;94(3):29. doi:10.3390/arm94030029

BibTeX
@article{Nigi2026,
  author = {Nigi, Akina and Iwamoto, Keisuke and Itani, Hidetoshi and Kondou, Shigeto and Okunishi, Yuki and Ohnishi, Takahiro},
  title = {Inflammatory Biomarkers and Outcome Heterogeneity in Anti-MDA5 Antibody-Associated Interstitial Lung Disease: A Single-Center Consecutive Cohort Study},
  journal = {Advances in Respiratory Medicine},
  year = {2026},
  volume = {94},
  number = {3},
  pages = {29},
  doi = {10.3390/arm94030029}
}
Kostenlos starten →